Maynard Um
-
-
-
-
-
-
-
GT Biopharma, Inc. (NASDAQ:GTBP) Offers Near-Term Catalyst Opportunity with Advancing Phase 1 Trials
-
-
-
-
-
-
-
GT Biopharma (GTBP) Requests Withdrawal of Form S-1 Registration Statement
-
-
-
-
-
397,807 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

